Metraipolis › archive › dc_08ff939b45d4
Abatacept — Wikipedia (en)
- Source
- Wikipedia (en)
- Original
- https://en.wikipedia.org/wiki/Abatacept
- License (as archived)
- CC-BY-SA-4.0
- Archived
- 2026-11-07T05:22:22.587Z
- SHA-256 of the archived text
cf8134020b53fd152f9acd3f961db3d7c82790744ea5a108f97073d728f23a08- Stable URL of this page
https://metraipolis.com/documento/dc_08ff939b45d4
How to cite
Abatacept — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/Abatacept (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_08ff939b45d4 (Metraipolis archive dc_08ff939b45d4, sha256 cf8134020b53fd152f9acd3f961db3d7c82790744ea5a108f97073d728f23a08)
BibTeX
@misc{dc08ff939b45d4,
title = {Abatacept — Wikipedia (en)},
howpublished = {Wikipedia (en)},
url = {https://en.wikipedia.org/wiki/Abatacept},
note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_08ff939b45d4; sha256 cf8134020b53fd152f9acd3f961db3d7c82790744ea5a108f97073d728f23a08},
year = {2026}
}Archived text
Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/Abatacept. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Abatacept, sold under the brand name Orencia, is a medication used to treat autoimmune diseases like rheumatoid arthritis, by interfering with the immune activity of T cells. It is a modified antibody. Abatacept is a fusion protein composed of the Fc region of the immunoglobulin IgG1 fused to the extracellular domain of CTLA-4. In order for a T cell to be activated and produce an immune response, an antigen-presenting cell must present two signals to the T cell. One of those signals is the major histocompatibility complex (MHC), combined with the antigen, and the other signal is the CD80 or CD86 molecule (also known as B7-1 and B7-2). Abatacept binds to the CD80 and CD86 molecule, and prevents the second signal. Without the second signal, the T cell can't be activated. Abatacept was developed by Bristol-Myers Squibb and is licensed in the United States for the treatment of rheumatoid arthritis in the case of inadequate response to anti-TNFα therapy. Abatacept received approval from the FDA in 2005. Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (deposito sistematico; retro-catalogo: tutte le voci di Wikipedia in inglese, in ordine alfabetico). Fonte: Wikipedia in inglese, voce «Abatacept» — https://en.wikipedia.org/wiki/Abatacept Wikidata Q2697833: «composto chimico» (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q2697833 Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/Abatacept?action=history). Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza. Estratto dell'introduzione non modificato nel contenuto; revisione 1384025157, consultata il 2026-11-07T05:20:13.361Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: e4af9535e777d9f0901d95b323bd6fdc40a7b7b6a1398db9be265a97777d3f49